Avvinity Therapeutics Limited Revenue and Competitors
Estimated Revenue & Valuation
- Avvinity Therapeutics Limited's estimated annual revenue is currently $2M per year.
- Avvinity Therapeutics Limited's estimated revenue per employee is $155,000
Employee Data
- Avvinity Therapeutics Limited has 13 Employees.
- Avvinity Therapeutics Limited grew their employee count by -13% last year.
Avvinity Therapeutics Limited's People
| Name | Title | Email/Phone |
|---|
Avvinity Therapeutics Limited Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Avvinity Therapeutics Limited?
Avvinity is developing novel immunotherapeutics targeted to cancer, harnessing a natural immune adaptation by humans and other primates.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avvinity Therapeutics Limited News
2022-04-13 - ESMO Scale for Clinical Actionability of Molecular Targets ...
Treatment options for advanced cholangiocarcinoma are limited and ... expand therapeutic opportunities in a chemotherapy-refractory setting.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 13 | N/A | N/A |
#2 | $1.1M | 13 | N/A | N/A |
#3 | $1.1M | 13 | N/A | N/A |
#4 | $1.1M | 13 | N/A | N/A |
#5 | $2.1M | 13 | N/A | N/A |